BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8099863)

  • 1. Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
    Bauer K; Dietersdorfer F; Kaik G
    Clin Pharmacol Ther; 1993 Jun; 53(6):675-83. PubMed ID: 8099863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors.
    Bauer K; Kaik G; Kaik B
    Hypertension; 1994 Sep; 24(3):339-46. PubMed ID: 7916004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.
    Lipworth BJ; Brown RA; McDevitt DG
    Br J Clin Pharmacol; 1989 Jul; 28(1):95-102. PubMed ID: 2570601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.
    Grove A; McFarlane LC; Lipworth BJ
    Thorax; 1995 Feb; 50(2):134-8. PubMed ID: 7701450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol.
    Palminteri R; Kaik G
    Eur J Clin Pharmacol; 1983; 24(6):741-5. PubMed ID: 6136412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of bronchial beta blockade after oral bevantolol.
    Mackay AD; Gribbin HR; Baldwin CJ; Tattersfield AE
    Clin Pharmacol Ther; 1981 Jan; 29(1):1-6. PubMed ID: 6109585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of penbutolol and propranolol on normal airway response to salbutamol.
    Warren JB; Monaghan AT; Clark TJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):47-50. PubMed ID: 6734048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary effects of long-term beta 2-blockade in healthy subjects: comparative study of metoprolol OROS.
    Bauer K; Rakusan S; Kaik G
    Am Heart J; 1990 Aug; 120(2):473-7. PubMed ID: 1974382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man.
    Tattersfield AE; Cragg DJ
    Br J Clin Pharmacol; 1983 Dec; 16(6):587-90. PubMed ID: 6140938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor responses to inhaled salbutamol in the elderly.
    Lipworth BJ; Tregaskis BF; McDevitt DG
    Br J Clin Pharmacol; 1989 Dec; 28(6):725-9. PubMed ID: 2558701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
    Löfdahl CG; Svedmyr K; Svedmyr N
    Pharmacotherapy; 1984; 4(4):205-10. PubMed ID: 6148733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic receptor changes during tertatolol treatment in healthy volunteers: relevance for beta-blocking therapy.
    De Blasi A; Lipartiti M; Garattini S
    Am J Nephrol; 1986; 6 Suppl 2():69-73. PubMed ID: 2879475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.